Filing Details
- Accession Number:
- 0001493152-21-012505
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-21 16:05:25
- Reporting Period:
- 2021-05-20
- Accepted Time:
- 2021-05-21 16:05:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1349929 | Vyant Bio Inc. | VYNT | Services-Medical Laboratories (8071) | 043462475 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1850320 | Yung-Ping Yeh | C/O Vyant Bio, Inc. 2 Executive Campus 2370 State Route 70, Suite 310 Cherry Hill, NJ 08002 | Chief Innovation Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value | Acquisiton | 2021-05-20 | 1,000 | $3.29 | 1,329,602 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
